Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Titel:
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Auteur:
Lukin, Dana Faleck, David Xu, Ronghui Zhang, Yiran Weiss, Aaron Aniwan, Satimai Kadire, Siri Tran, Gloria Rahal, Mahmoud Winters, Adam Chablaney, Shreya Koliani-Pace, Jenna L. Meserve, Joseph Campbell, James P. Kochhar, Gursimran Bohm, Matthew Varma, Sashidhar Fischer, Monika Boland, Brigid Singh, Siddharth Hirten, Robert Ungaro, Ryan Lasch, Karen Shmidt, Eugenia Jairath, Vipul Hudesman, David Chang, Shannon Swaminath, Arun Shen, Bo Kane, Sunanda Loftus Jr., Edward V. Sands, Bruce E. Colombel, Jean-Frederic Siegel, Corey A. Sandborn, William J. Dulai, Parambir S.